Free tool
Healthcare stocks
We cover 90 companies in the Healthcare sector. The median market value in the group is $1.21B. Across the group, the median move over the past trading day is +0.32%. 64% of the 86 with a 200-day average trade above it. Price change over the past year runs from −37.1% to +147.5% across the middle 80 percent of the group, with a median of +3.5%.
Other lists in this group
Table
90 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 231.95 EUR | +4.22% | +33.52% | +57.15% | Oct 13, 2026 |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% | Oct 27, 2026 |
| NOT.DE | Novartis AG | 135.44 EUR | −1.17% | +18.59% | +28.48% | Oct 27, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 539.00 EUR | +10.07% | +7.26% | +28.91% | Oct 21, 2026 |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 246.60 SEK | +4.45% | +16.11% | +21.94% | Oct 21, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 373,500.00 KRW | +7.02% | −47.76% | +11.33% | Oct 23, 2026 |
| 3391.T | Tsuruha Holdings Inc. | 2,343.50 JPY | −8.30% | −17.79% | +4.03% | Oct 9, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% | Oct 27, 2026 |
| SECT-B.ST | Sectra AB (publ) | 295.40 SEK | +5.88% | +23.29% | −10.34% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% | Sep 1, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% | Oct 23, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,524.00 JPY | −5.17% | −15.10% | −25.81% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | 323.00 EUR | −5.42% | −8.63% | −3.58% | Sep 17, 2026 |
| ARQT | Arcutis Biotherapeutics, Inc. | $25.14 | −11.54% | −13.31% | +60.64% | Oct 27, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | 1,321.00 JPY | −55.52% | −63.75% | −64.23% | Oct 8, 2026 |
| HYPE3.SA | Hypera S.A. | 22.01 BRL | +2.66% | −4.58% | −4.69% | Oct 27, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,196.00 JPY | +0.05% | −6.21% | +8.81% | Oct 1, 2026 |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% | Oct 27, 2026 |
| EMEIS.PA | emeis Société anonyme | 12.60 EUR | −13.40% | −13.82% | +3.19% | Sep 23, 2026 |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% | Oct 27, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| NANO.PA | Nanobiotix S.A. | 38.28 EUR | +13.05% | +101.47% | +387.64% | Sep 29, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | 38,950.00 KRW | +17.50% | −18.85% | −17.57% | Oct 26, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 167.90 SEK | +3.32% | +11.90% | −4.16% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,338.00 GBP | +4.19% | −8.13% | −10.24% | Sep 10, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.60 SEK | +3.19% | +16.04% | +14.54% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | 29.15 DKK | +1.92% | −8.91% | −5.97% | Oct 20, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 230.20 SEK | +4.54% | +29.33% | −25.84% | Oct 22, 2026 |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% | Oct 21, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% | Sep 14, 2026 |
| DIA.WA | Diagnostyka S.A. | 168.40 PLN | +0.42% | −2.60% | −16.84% | Sep 10, 2026 |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% | Sep 8, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | 11.00 EUR | +0.46% | +17.77% | +10.00% | Oct 16, 2026 |
| VITR.ST | Vitrolife AB (publ) | 97.10 SEK | +12.45% | −26.24% | −28.19% | Oct 22, 2026 |
| 9627.T | Ain Holdings Inc. | 6,228.00 JPY | +1.24% | −4.41% | +3.62% | Sep 14, 2026 |
| CHEMM.CO | ChemoMetec A/S | 503.50 DKK | +16.01% | −25.35% | −2.37% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.07% | +40.25% | +9.22% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 116.50 SEK | +0.60% | +14.46% | +14.57% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | 1,300.80 GBP | +3.98% | +2.10% | +5.94% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | 4.24 EUR | +7.90% | +4.70% | −13.48% | Sep 25, 2026 |
| TTALO.HE | Terveystalo Oyj | 7.76 EUR | +3.19% | −16.42% | −22.07% | Oct 21, 2026 |
| IVA | Inventiva S.A. | $4.82 | +3.88% | +1.26% | −7.84% | Sep 25, 2026 |
| GXI.DE | Gerresheimer AG | 25.40 EUR | −8.70% | −8.63% | −41.09% | Sep 16, 2026 |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.79% | +10.38% | +31.25% | Oct 15, 2026 |
| VETO.PA | Vetoquinol SA | 70.90 EUR | −2.48% | −16.00% | −6.46% | Sep 11, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 283.00 SEK | +8.51% | +56.27% | +68.75% | Oct 22, 2026 |
| 3046.T | JINS HOLDINGS Inc. | 6,020.00 JPY | −10.15% | +10.45% | −23.78% | Oct 9, 2026 |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +0.54% | +4.03% | −9.69% | Oct 23, 2026 |
| GNFT.PA | Genfit S.A. | 14.74 EUR | +5.29% | +180.76% | +327.25% | Sep 29, 2026 |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% | Oct 27, 2026 |
| OXB.L | Oxford Biomedica plc | 532.00 GBP | −5.84% | −18.78% | −6.01% | Sep 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | 77.50 SEK | +8.24% | −20.89% | −38.08% | Oct 21, 2026 |
| ARJO-B.ST | Arjo AB (publ) | 28.18 SEK | +2.92% | −7.54% | −15.46% | Oct 22, 2026 |
| PHR | Phreesia, Inc. | $11.60 | +6.81% | −28.83% | −63.74% | Sep 2, 2026 |
| SSII | SS Innovations International, Inc. | $3.57 | −9.16% | −36.81% | −50.55% | Oct 27, 2026 |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% | Oct 1, 2026 |
| TLRY.TO | Tilray Brands, Inc. | 6.46 CAD | +13.73% | −51.61% | +240.00% | Oct 8, 2026 |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% | Oct 8, 2026 |
| EQS.PA | Equasens Société anonyme | 33.45 EUR | −1.91% | −25.42% | −26.89% | Sep 28, 2026 |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +2.85% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | 15.02 EUR | +21.92% | −32.04% | −37.02% | Sep 8, 2026 |
| 4592.T | SanBio Company Limited | 1,032.00 JPY | +14.16% | −36.96% | −55.46% | Sep 14, 2026 |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% | Oct 26, 2026 |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% | Sep 22, 2026 |
| PRTC.L | PureTech Health plc | 126.60 GBP | +5.85% | +1.61% | +2.43% | Sep 3, 2026 |
| CRNA.OL | Circio Holding ASA | 14.20 NOK | +67.85% | +1063.93% | +2220.26% | Aug 31, 2026 |
| NIOX.L | NIOX Group Plc | 68.80 GBP | +14.29% | +1.20% | −9.45% | Sep 29, 2026 |
| HUM.ST | Humana AB (publ) | 71.00 SEK | +11.99% | +44.70% | +80.96% | Oct 22, 2026 |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% | Sep 29, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.91 EUR | +22.49% | +17.95% | +3.36% | Sep 17, 2026 |
| TRMED.OL | Thor Medical ASA | 6.15 NOK | +36.06% | +22.75% | +92.19% | Aug 28, 2026 |
| SY | So-Young International Inc. | $2.40 | +22.45% | −10.11% | −38.93% | Aug 31, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.23% | +12.80% | −2.52% | Sep 17, 2026 |
| UTMD | Utah Medical Products, Inc. | $70.89 | −0.10% | +26.08% | +17.76% | Oct 22, 2026 |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% | Sep 14, 2026 |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% | Aug 31, 2026 |
| ALCGM.PA | Cegedim SA | 10.36 EUR | +2.17% | −25.20% | −2.72% | Sep 24, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | 13.70 SEK | +38.38% | +27.80% | −7.43% | Oct 22, 2026 |
| ENGN | enGene Therapeutics Inc. | $1.95 | +10.80% | −77.97% | −55.07% | Sep 14, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| NAUT | Nautilus Biotechnology, Inc. | $0.94 | −21.88% | −50.92% | +33.34% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.